Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 11
Submit an article Journal homepage
819
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study

Qiu TanGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
,
Qi ZhuGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
,
Huanying ZhengGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
,
Bing ZhangGuangdong Institute of Public Health, Guangzhou, Guangdong, China
,
Chenggang WuGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
,
Xue GuoGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
,
Hui LiGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
,
Leng LiuGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
,
Yu LiuGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
,
Shannon RutherfordCenter for Environment and Population Health, School of Environment, Griffith University, Brisbane, Queensland, Australia
&
Huizhen ZhengGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, ChinaCorrespondence[email protected]
 show all
Pages 2644-2648 | Received 22 Mar 2018, Accepted 08 Jun 2018, Published online: 30 Jul 2018

References

  • World Health Organization. Polio vaccine: WHO position paper-March 2016.
  • Estívariz CF, Watkins MA, Handoko D, Rusipah R, Deshpande J, Rana BJ, et al. A large vaccine-derived poliovirus outbreak on Madura Island–Indonesia. J Inf Dis. 2005;197:347–54. doi:10.1086/525049.
  • Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Mwanza M, Corander J, Garnier S, Chauvin C, Abanida E, Pate MA, et al. Implicastions of a circulating vaccine-derived poliovirus in Nigeria. N Eng J Med. 2010;362:2360–9. doi:10.1056/NEJMoa0910074.
  • Duintjer Tebbens RJ, Pallansch MA, Kim JH, Burns CC, Kew OM, Oberste MS, Wassilak SG, Cochi SL, Thompson KM. Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). Risk Anal. 2013;23(4):680–702. doi:10.1111/risa.12022.
  • World Health Organization. 2013. Polio Eradication and Endgame Strategic Plan 2013–2018.
  • Zheng H-Z, Deng H-H. Practice of immunization program in Guangdong province; 2011.
  • CDC. Wild poliovirus type 1 and type 3 importations—15 countries, Africa, 2008–2009. MMWR Morb Mortal Wkly Rep. 2009 Apr 17;58(14):357–62.
  • CDC. Outbreaks following wild poliovirus importations—Europe, Africa, and Asia, January 2009-September 2010. MMWR Morb Mortal Wkly Rep. 2010 Nov 5;59(43):1393–9.
  • Yakovenko ML, Gmyl AP, Ivanova OE, Eremeeva TP, Ivanov AP, Prostova MA, Baykova OY, Isaeva OV, Lipskaya GY, Shakaryan AK, et al. The 2010 outbreak of poliomyelitis in Tajikistan: epidemiology and lessons learnt. Euro Surveill. 2014 Feb 20;19(7):20706. doi:10.2807/1560-7917.ES2014.19.7.20706.
  • World Health Organization. Progress toward interruption of wild poliovirus transmission-worldwide, 2008. Morb Mortal Wkly Rep. 2009;58(12):308–12.
  • Alexander JP, Ehresmann K, Seward J, Wax G, Harriman K, Fuller S, et al. Transmission of imported vaccine-derived poliovirus in an under vaccinated community in minnesota. J Inf Dis. 2009;199(3):391–7. doi:10.1086/596052.
  • Guo X, Liu L, Deng W, Xu Y, Zheng H-Y, Zhu S-Y, et al. Analysis of Poliomyelitis neutralizing antibody level in healthy population in Guangdong Province in 2010. Chinese Journal of Vaccines and Immunization. 2013;19(1):27–30.
  • You E-K, Yang Q-Z, Yang Q-L. Serum epidemiological study on the vertical distribution of polio neutralizing antibodies. Chinese Journal of epidemiology. 1994;15(3):158–61.
  • Hu F-J, Zhang S-M, Lou L-B. Check and measure of poliomyelitis antibody in newborn babies. Chinese Journal of Expanded Immunization programme. 2000;6(2):75–76.
  • Li Xiaomei, Zhang Herun, Wang Yumei, Liu Donglei, Zou Yanjie, Wang Dongmei. Analysis of polio antibody levels in healthy population in Beijing in 2007. Chinese Journal of Vaccines and Immunization. 2009;15(3):245–8.
  • Gamage D, Palihawadana P, Mach O, Weldon WC, Oberste SM, Sutter RW. Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014. J Epidemiol Glob Health. 2015 Dec;5(4 Suppl 1):S67–71. doi:10.1016/j.jegh.2015.06.004.
  • Claudia R, Imke F, Holger F, Hans WD. Deficiency of immunity to poliovirus type 3:a lurking danger? BMC Infectious Diseases. 2012;12(1):12–24.
  • Roivainen M, Montagnon B, Chalumeau H, Murray M, Wimmer E, Hovi T. Improved distribution of antigenic site specificity of poliovirusneutralizing antibodies induced by a protease-cleaved immunogen in mice. J Virol 1990;64(2):559–62.
  • Chang Z, Feng D-X, Xu J, Feng Z-J, Chen M-G. Surveillance of Immune Level of Poliomyel itis in Healthy Population of Henan Province in 1998 Henan Provincial Epidemic Prevent ion Station, Zhengzhou 450003, China.
  • Wu Y, Leng H-Y, Ye X, Hu Y, Deng X-Y, Lu P-S. Analysis of polio antibody levels in healthy population in Jiangsu province in 2011. Chinese Primary Health Care. 2012;26(5):76–77.
  • World Health Organization. Manual for the virological investigation of polio. WHO. 1997 EPI/GEN/97.01.EPI. World Health Organization, Geneva, Switzerland.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.